Biological networks such as protein networks provide an integrated perspective on how proteins work together and are becoming important tools to study neuropsychiatric disorders such as schizophrenia. Mass spectrometry (MS) based proteomics are rapidly advancing and are now capable of quantifying proteins with increased sensitivity and throughput, which provide critical data sources for protein networks and have been emerging as important application in the study of psychiatric diseases. For example, in our recent study, the synaptic protein co-expression network was found to be altered in the auditory cortex of schizophrenia patients. Whereas a variety of network analysis methods have now been developed for microarray data, methodologies customized to proteomic data are lagging far behind. In addition, these methods mainly focus on pairwise marginal correlations while ignoring the joint effects from other genes when constructing the network, failing to distinguish causal interactions from correlations via intermediate genes. Moreover, most existing methods for network testing are permutation based, from which the p-values could be invalid if the permutation-based null distribution is inaccurate. The probabilistic graphical model based differential network inference is more desirable as it infers conditional dependency by adjusting for the joint effects from all other proteins and guarantees to be valid and powerful when the distributional assumptions are satisfied. The objective of our proposed research is to develop, validate and apply novel and robust statistical methods to construct, analyze and infer protein networks from two popular proteomic platforms, namely, the targeted- MS and the unbiased differential-MS. The novel methodology will be immediately applied to the ongoing schizophrenia projects at the University of Pittsburgh, to facilitate novel analyses to identify protein alterations contributing to the disease pathology. First, we will develop novel network construction methodology based on a partial-correlation-based approach, which is under the Gaussian Graphical Model (GGM) framework and quantifies the correlation between two proteins after excluding the effects of other proteins, for protein network construction. Then, we will develop a novel differential network inference procedure, based on the recent development of GGM theory and associated inference, to formally test network differences. Finally, we will thoroughly validate the proposed methods using both statistically simulated data and the real data from a biological model with well characterized network interactions. Robustness of the networks will be assessed using rigorously designed replicate experiments with samples from post-mortem brain tissues of normal subjects. In summary, the novel methods and findings from this research will provide critical guidance for the design, analysis and validation of ongoing and future network studies that utilize proteomics approaches in psychiatric disorders, which will greatly improve the sensitivity and validity of the consequent scientific findings.

Public Health Relevance

The goal of this proposal is to develop, validate and apply novel and robust statistical methods to construct, analyze and infer protein networks from proteomic platforms in schizophrenia studies. We expect the novel methods and findings from this research will enhance the design, analysis and validation of ongoing and future network studies that utilize proteomics approaches in psychiatric disorders, which will greatly improve the sensitivity and reproducibility of the consequent scientific findings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Research Grants (R03)
Project #
5R03MH108849-02
Application #
9304868
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Freund, Michelle
Project Start
2016-07-01
Project End
2018-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
McKinney, Brandon C; Lin, Huang; Ding, Ying et al. (2018) DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia. Schizophr Res 196:39-44
Krivinko, Josh M; Erickson, Susan L; Ding, Ying et al. (2018) Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease. Am J Psychiatry 175:999-1009
McKinney, B; Ding, Y; Lewis, D A et al. (2017) DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia. Transl Psychiatry 7:e1032
Sweet, Robert A; MacDonald, Matthew L; Kirkwood, Caitlin M et al. (2016) Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease. Mol Cell Proteomics 15:2252-62
Wang, Ting; Ren, Zhao; Ding, Ying et al. (2016) FastGGM: An Efficient Algorithm for the Inference of Gaussian Graphical Model in Biological Networks. PLoS Comput Biol 12:e1004755
Kirkwood, Caitlin M; MacDonald, Matthew L; Schempf, Tadhg A et al. (2016) Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration. J Neuropathol Exp Neurol 75:175-82